Whats New
NEWS FEED
January 22, 2013 -Edge Therapeutics Appoints Dr. Sol Barer and Isaac Blech as Chairman and Vice Chairman of Its Board of Directors
December 11, 2012 - Bert Marchio, Edge CFO, featured in CFO Studio Magazine
October 1, 2012 - Edge CEO Brian Leuthner featured in CEO CFO Magazine
August 22, 2012 - Press Release – Edge Therapeutics Appoints Drug-delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
June 28, 2012 - Press Release – Edge and Three Other Companies Meet With Lt. Governor Kim Guadagno
June 14, 2012 – Edge featured in CFO Studio Interview
June 8, 2012 – Press Release – Government of Canada Awards CA$700,000 Toward Phase 2 Study of Edge Therapeutics’ Lead Compound to Improve Outcomes After Brain Injury
April 3, 2012 – Press Release – MPI Research and Edge Therapeutics Partner to Advance Development of Life-Saving Therapies After Brain Hemorrhage
March 16, 2012 - Edge featured in NJ Business Incubation Network Newsletter
December 2, 2011 – Press Release - Edge Receives Success Award from NJ Small Business Development Centers
November 17, 2011 – Press Release - Edge Appoints Dr. James J. Loughlin to Board of Directors
September 7, 2011 – Press Release - Edge Appoints Dr. Sol J. Barer to Board
September 7, 2011 – Press Release - Edge Presenting at Rodman Renshaw
April 8, 2011 - Edge featured in Start-Up Magazine
March 15, 2011 – Edge featured in BioCentury
February 11, 2011 – Press Release - NimoGelâ„¢ Shows Promise at Preventing Delayed Complications of Sudden Brain Injury in a Preclinical Study Presented at the International Stroke Conference
February 8, 2011 – International Stroke Conference Abstracts – Effect of Site-Specific, Sustained-Release Nimodipine on Vasospasm After Subarachnoid Hemorrhage in Dogs
December 10, 2010 – Edge Therapeutics Featured in Drug Discovery News
November 22, 2010 – Edge Therapeutics Featured in Drug Delivery Technology
November 3, 2010 - Press Release - SurModics and Edge Therapeutics Collaborate on Development of Sustained-Release Neurological Product
November 3, 2010 – Edge Therapeutics Awarded $244,479 Qualifying Therapeutic Development Project Grant
October 27, 2010 – Press Release - Edge Therapeutics Named Incubator Company to Watch by New Jersey Technology Council
October 4, 2010 – Site-specific, Sustained-release Nimodipine to Prevent Vasospasm
July 21, 2010 - Press Release - Edge Therapeutics and SurModics Collaborate to Develop a Drug Delivery Technology for Treatment of Secondary Brain Injury After Stroke or Traumatic Brain Injury (TBI)
July 08, 2010 – Press Release - The New Jersey Economic Development Authority Awards Funding to Edge Therapeutics for Treatments to Prevent Secondary Brain Damage after Sudden Brain Injury
June 17, 2010 – Press Release - Edge Therapeutics Appoints Scientific Advisory Board Members and Business Advisors
